Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation
Integrative Biomedical Research · 01.04.2026 · 10 (1) · 1-8
DOI: 10.25163/biomedical.10110880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Biomedical Research, online erschienen am 01.04.2026.
Abstract (Originalsprache)
Cellular senescence, an essentially irreversible growth arrest first described in cultured fibroblasts, is now recognized as a druggable driver of multiple age-related diseases, yet clinical progress has been slowed by the marked heterogeneity of senescent cells across tissues, inducing stressors, and disease states. We conducted a structured narrative synthesis of peer-reviewed literature senescence biology, single-cell senotyping, and senotherapeutic development, following informed search and appraisal strategy across PubMed/MEDLINE, Scopus, and Web of Science. Sixty-plus primary and review sources were synthesized into four evidence tables spanning first-generation agents, precision platforms, multi-tissue biomarkers, and human trials. First-generation senolytics (dasatinib plus quercetin, fisetin, navitoclax) demonstrate proof-of-concept efficacy but are constrained by dose-limiting toxicities, whereas next-generation platforms—PROTAC degraders, uPAR-directed CAR-T cells, senolytic vaccines, and galactose-caged prodrugs—achieve markedly higher predicted selectivity with lower off-target risk, operating through convergent mechanistic nodes upstream of tissue-level inflammaging. Early-phase human trials corroborate target engagement but remain underpowered for definitive efficacy claims. Precision senotherapy is mechanistically justified and clinically nascent; its translational success will depend on resolving the biomarker bottleneck and matching senotype-specific vulnerabilities to intervention class.
Zitieren
APA
(2026). Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation. Integrative Biomedical Research, 10(1), 1-8. https://doi.org/10.25163/biomedical.10110880
Vancouver
Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation. Integrative Biomedical Research. 2026;10(1):1-8. doi:10.25163/biomedical.10110880
BibTeX
@article{euvimed2026,
title = {Senescent Cell Heterogeneity and Precision Clearance Strategies: From Molecular Mechanism to Clinical Translation},
journal = {Integrative Biomedical Research},
year = {2026},
volume = {10},
number = {1},
pages = {1--8},
doi = {10.25163/biomedical.10110880}
}
EUVIMED